Literature DB >> 33356973

A conserved arginine residue in a staphylococcal anti-sigma factor is required to preserve its kinase activity, structure, and stability.

Debasmita Sinha1, Debabrata Sinha1, Nilanjan Banerjee2, Priya Rai2, Soham Seal1, Tushar Chakraborty1, Subhrangsu Chatterjee2, Subrata Sau1.   

Abstract

RsbW, σB, and RsbV, encoded by Staphylococcus aureus and related bacteria, act as an anti-sigma factor, an sigma factor, and an anti-anti-sigma factor, respectively. The interaction between RsbW and σB blocks the transcription initiation activity of the latter protein. RsbW also functions as a serine kinase and phosphorylates RsbV in the presence of ATP. Our modeling study indicates that the RsbW-RsbV complex is stabilized by twenty-four intermolecular non-covalent bonds. Of the bond-forming RsbW residues, Arg 23, and Glu 49 are conserved residues. To understand the roles of Arg 23 in RsbW, rRsbW[R23A], a recombinant S. aureus RsbW (rRsbW) harboring Arg to Ala change at position 23, was investigated using various probes. The results reveal that rRsbW[R23A], like rRsbW, exists as the dimers in the aqueous solution. However, rRsbW[R23A], unlike rRsbW, neither interacted with a chimeric RsbV (rRsbV) nor formed the phosphorylated rRsbV in the presence of ATP. Furthermore, the tertiary structure and hydrophobic surface area of rRsbW[R23A] matched little with those of rRsbW. Conversely, both rRsbW[R23A] and rRsbW showed interaction with a recombinant σB (rσB). rRsbW and rRsbW[R23A] were also unfolded via the formation of at least one intermediate in the presence of urea. However, the thermodynamic stability of rRsbW significantly differed from that of rRsbW[R23A]. Our molecular dynamics (MD) simulation study also reveals the substantial change of structure, dimension, and stability of RsbW due to the above mutation. The ways side chain of critical Arg 23 contributes to maintaining the tertiary structure, and stability of RsbW was elaborately discussed.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  Anti-sigma factor; arginine; function; stability; structure

Mesh:

Substances:

Year:  2020        PMID: 33356973     DOI: 10.1080/07391102.2020.1864475

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102            Impact factor:   5.235


  4 in total

1.  Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors.

Authors:  Anshul Shakya; Rupesh V Chikhale; Hans Raj Bhat; Fatmah Ali Alasmary; Tahani Mazyad Almutairi; Surajit Kumar Ghosh; Hassna Mohammed Alhajri; Siham A Alissa; Shuchi Nagar; Md Ataul Islam
Journal:  Mol Divers       Date:  2021-03-30       Impact factor: 2.943

2.  Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis.

Authors:  Rupesh Chikhale; Saurabh K Sinha; Manish Wanjari; Nilambari S Gurav; Muniappan Ayyanar; Satyendra Prasad; Pukar Khanal; Yadu Nandan Dey; Rajesh B Patil; Shailendra S Gurav
Journal:  Mol Divers       Date:  2021-01-25       Impact factor: 3.364

3.  Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.

Authors:  Bhaskarjyoti Gogoi; Purvita Chowdhury; Nabajyoti Goswami; Neelutpal Gogoi; Tufan Naiya; Pankaj Chetia; Saurov Mahanta; Dipak Chetia; Bhaben Tanti; Probodh Borah; Pratap Jyoti Handique
Journal:  Mol Divers       Date:  2021-04-15       Impact factor: 3.364

4.  Informing selection of drugs for COVID-19 treatment through adverse events analysis.

Authors:  Wenjing Guo; Bohu Pan; Sugunadevi Sakkiah; Zuowei Ji; Gokhan Yavas; Yanhui Lu; Takashi E Komatsu; Madhu Lal-Nag; Weida Tong; Tucker A Patterson; Huixiao Hong
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.